These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35563197)

  • 41. Reversing deleterious protein aggregation with re-engineered protein disaggregases.
    Jackrel ME; Shorter J
    Cell Cycle; 2014; 13(9):1379-83. PubMed ID: 24694655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
    Singh N; Haldar S; Tripathi AK; McElwee MK; Horback K; Beserra A
    Antioxid Redox Signal; 2014 Jul; 21(3):471-84. PubMed ID: 24512387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances in bioanalytical methods to measure proteome stability in cells.
    Zhang S; Greening DW; Hong Y
    Analyst; 2021 Apr; 146(7):2097-2109. PubMed ID: 33635299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polyglutamine misfolding in yeast: toxic and protective aggregation.
    Duennwald ML
    Prion; 2011; 5(4):285-90. PubMed ID: 22052348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
    Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
    Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
    Ries HM; Nussbaum-Krammer C
    Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A review on protein misfolding, aggregation and strategies to prevent related ailments.
    Shamsi TN; Athar T; Parveen R; Fatima S
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
    Kanemaru K
    Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular Proteostasis in Neurodegeneration.
    Kurtishi A; Rosen B; Patil KS; Alves GW; Møller SG
    Mol Neurobiol; 2019 May; 56(5):3676-3689. PubMed ID: 30182337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurodegenerative disorders: dysregulation of a carefully maintained balance?
    Swart C; Haylett W; Kinnear C; Johnson G; Bardien S; Loos B
    Exp Gerontol; 2014 Oct; 58():279-91. PubMed ID: 25219768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
    Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
    Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.
    Bosco DA; LaVoie MJ; Petsko GA; Ringe D
    Cold Spring Harb Perspect Biol; 2011 Oct; 3(10):a007500. PubMed ID: 21844169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
    Iram A; Naeem A
    Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vulnerability of newly synthesized proteins to proteostasis stress.
    Xu G; Pattamatta A; Hildago R; Pace MC; Brown H; Borchelt DR
    J Cell Sci; 2016 May; 129(9):1892-901. PubMed ID: 27026526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aptamer and its applications in neurodegenerative diseases.
    Qu J; Yu S; Zheng Y; Zheng Y; Yang H; Zhang J
    Cell Mol Life Sci; 2017 Feb; 74(4):683-695. PubMed ID: 27563707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the Role of Normal Aging Processes in the Onset and Pathogenesis of Diseases Associated with the Abnormal Accumulation of Protein Aggregates.
    Ilyinsky NS; Nesterov SV; Shestoperova EI; Fonin AV; Uversky VN; Gordeliy VI
    Biochemistry (Mosc); 2021 Mar; 86(3):275-289. PubMed ID: 33838629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease.
    Skibinski G; Finkbeiner S
    FEBS Lett; 2013 Apr; 587(8):1139-46. PubMed ID: 23458259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes.
    Sin O; Nollen EA
    Cell Mol Life Sci; 2015 Nov; 72(21):4027-47. PubMed ID: 26190021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.